Gri Bio Inc (GRI)

04:32 AM

GRI Bio closes $8 million public offering of common stock and warrants By Investing.com - Investing.com South Africa

04:32 AM

04:05 AM

GRI Bio (NASDAQ: GRI) closes $8.0M offering of 10,666,667 shares, warrants - Stock Titan

04:05 AM

09:03 AM

GRI Bio Launches $6.7 Million Public Offering - TipRanks

09:03 AM

Dec 11, 2025

GRI Bio prices $8 million public offering at $0.75 per share - Investing.com

Dec 11, 2025

Dec 11, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Dec 11, 2025

Dec 11, 2025

GRI Bio announces pricing of $8M public offering - MSN

Dec 11, 2025

Dec 11, 2025

GRI Bio (NASDAQ: GRI) prices $8,000,000 offering of 10,666,667 shares at $0.75 - Stock Titan

Dec 11, 2025

Dec 11, 2025

What's Going On With GRI Bio Stock Thursday?GRI Bio (NASDAQ:GRI) - Benzinga

Dec 11, 2025

Dec 11, 2025

GRI Bio Meets Key Goals In Phase 2 Trial Of GRI-0621 For Idiopathic Pulmonary Fibrosis - Nasdaq

Dec 11, 2025

Dec 10, 2025

GRI Bio’s IPF drug shows positive Phase 2a results with improved lung function - Investing.com

Dec 10, 2025

Dec 10, 2025

GRI Bio Announces Positive Phase 2a Trial Results - TipRanks

Dec 10, 2025

Dec 10, 2025

GRI Bio, Inc. Announces Positive Phase 2a Trial Results for GRI-0621 - TradingView

Dec 10, 2025

Dec 10, 2025

GRI Bio (NASDAQ: GRI) unveils Phase 2a IPF results showing favorable safety and collagen biomarker shifts - Stock Titan

Dec 10, 2025

Dec 09, 2025

A new trading data show Milestone Pharmaceuticals Inc (MIST) is showing positive returns. - Setenews

Dec 09, 2025

Dec 09, 2025

Financial Contrast: CalciMedica (NASDAQ:CALC) and GRI Bio (NASDAQ:GRI) - Defense World

Dec 09, 2025

Dec 08, 2025

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com UK

Dec 08, 2025

Dec 08, 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com

Dec 08, 2025

Dec 08, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Dec 08, 2025

Dec 08, 2025

GRI Bio Reports Positive Phase 2a Trial Results - TipRanks

Dec 08, 2025

Dec 08, 2025

GRI Bio Increceives topline data from phase 2a trial for idiopathic pulmonary fibrosisSEC filing - marketscreener.com

Dec 08, 2025

Dec 08, 2025

GRI Bio Reports Positive Phase 2a Trial Results for IPF Treatment - TradingView

Dec 08, 2025

Dec 08, 2025

Ascendiant Capital Maintains GRI Bio (GRI) Buy Recommendation - Nasdaq

Dec 08, 2025

Dec 08, 2025

Ascendiant Capital Raises Price Target for GRI to $36.00 | GRI S - GuruFocus

Dec 08, 2025

Dec 05, 2025

Why GRI Bio Inc. stock is seen as undervaluedSell Signal & Weekly Return Optimization Alerts - Newser

Dec 05, 2025

Dec 03, 2025

JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 - The Herald-Mail

Dec 03, 2025

Dec 02, 2025

GRI Bio receives Nasdaq notice for non-compliance with equity listing rule - Investing.com Australia

Dec 02, 2025

Dec 01, 2025

GRI Bio (GRI) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Dec 01, 2025

GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 01, 2025

Nov 29, 2025

What insider trading reveals about GRI Bio Inc. stockWeekly Gains Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ

Nov 29, 2025

Nov 28, 2025

Stop Loss: What sentiment indicators say about GRI Bio Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Buy Signal: What insider trading reveals about GRI Bio Inc. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

This trade activity should not be overlooked: GRI Bio Inc (GRI) - Setenews

Nov 27, 2025

Nov 27, 2025

Wall Street analysts’ outlook for Moolec Science SA (MLEC) - Setenews

Nov 27, 2025

Nov 27, 2025

A better buy-in window may exist right now for Movano Inc (MOVE) - Setenews

Nov 27, 2025

Nov 25, 2025

GRI Bio Inc Stock Analysis and ForecastRisk Mitigation Techniques & Rapid Capital Appreciation - earlytimes.in

Nov 25, 2025

Nov 24, 2025

GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF') - ADVFN

Nov 24, 2025

Nov 24, 2025

GRI Stock Price and Chart — NASDAQ:GRI - TradingView

Nov 24, 2025

Nov 21, 2025

The growth track for GRI Bio Inc (GRI) has changed recently - Setenews

Nov 21, 2025

Nov 20, 2025

What technical charts say about GRI Bio Inc. stock2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com

Nov 20, 2025

Nov 19, 2025

How GRI Bio Inc. stock benefits from strong dollarShare Buyback & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

GRI Bio Inc. stock daily chart insightsWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Visual analytics tools that track GRI Bio Inc. performanceBond Market & Reliable Price Breakout Signals - newser.com

Nov 19, 2025

Nov 18, 2025

How supply chain issues affect GRI Bio Inc. stock2025 Top Decliners & Daily Profit Focused Screening - newser.com

Nov 18, 2025

Nov 17, 2025

Will GRI Bio Inc. stock see insider buyingMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com

Nov 17, 2025

Nov 16, 2025

Using economic indicators to assess GRI Bio Inc. potentialInsider Selling & Technical Pattern Based Buy Signals - newser.com

Nov 16, 2025

Nov 16, 2025

Will GRI Bio Inc. stock outperform value stocksJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com

Nov 16, 2025